FDA Approved: PALONOSETRON — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved Fresenius Kabi USA, LLC's original application for Palonosetron, a 5-HT3 receptor antagonist used to prevent chemotherapy-induced and postopera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

ORIG AP for PALONOSETRON (PALONOSETRON)